SCHEMBL2183194

SCHEMBL2183194

Cn1c(=O)c2nc(NCCN)nnc2n(Cc2cccnc2)c1=O

nearest known ligand 0.46

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
THRB P10828 1/20 0.46
ALDH1A1 P00352 5/20 0.44
MAPK1 P28482 1/20 0.43
GRIN1 Q05586 7/20 0.42
GRIN2B Q13224 7/20 0.42
HIF1A Q16665 3/20 0.42
HTT P42858 1/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
LMNA P02545 1/20 0.42
PARG Q86W56 2/20 0.41
POLB P06746 1/20 0.41
HPGD P15428 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
PKM P14618 1/20 0.40
GAA P10253 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2180765 0.94 ALDH1A1 (0.42) THRBALDH1A1MAPK1GRIN1GRIN2B
SCHEMBL2181371 0.90 ALDH1A1 (0.44) ALDH1A1MAPK1GRIN1GRIN2BHIF1A
SCHEMBL2183235 0.89 ALDH1A1 (0.42) ALDH1A1MAPK1GRIN1GRIN2BHIF1A
SCHEMBL2182059 0.89 ALDH1A1 (0.42) ALDH1A1MAPK1GRIN1GRIN2BHIF1A
SCHEMBL2182256 0.88 PCSK9 (0.42) ALDH1A1MAPK1GRIN1GRIN2BHIF1A
SCHEMBL2184411 0.87 ALDH1A1 (0.41) ALDH1A1MAPK1GRIN1GRIN2BHIF1A
SCHEMBL2179044 0.87 HIF1A (0.42) ALDH1A1MAPK1GRIN1GRIN2BHIF1A
SCHEMBL2184025 0.87 PCSK9 (0.41) ALDH1A1MAPK1GRIN1GRIN2BHIF1A
SCHEMBL2179603 0.86 ALDH1A1 (0.41) ALDH1A1MAPK1GRIN1GRIN2BHIF1A
SCHEMBL2181653 0.86 CHRNB2 (0.41) ALDH1A1MAPK1GRIN1GRIN2BHIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110166144-A1 Pyrimidotriazinediones and Pyrimidopyrimidinediones and Methods of Using the Same THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2011-07-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110166144-A1 Pyrimidotriazinediones and Pyrimidopyrimidinediones and Methods of Using the Same DPYD, TYMP, DHFR THRB 2811/4885ALDH1A1 245/4885MAPK1 3843/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.